As the latest study described, early radiological response could identify a subgroup of patients with EGFR mutation, and patients with exon 21 L858R had a poor prognosis in spite of the treatment with TKI.[29] Therefore, it is strongly recommended to identify the subtype of EGFR mutation in the clinical treatment of lung cancer. This evidence concerns the gene EGFR and lung carcinoma.